For Quick Alerts
For Daily Alerts

Shares in Natco Rally On Hepatitis Approval


Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange.


Shares in Natco Rally On Hepatitis Approval
Natco Pharma: Quotes, News
BSE 1018.00BSE Quote1.95 (0.19%)
NSE 1024.05NSE Quote5.65 (0.55%)
It also hit a new 52-week high of Rs 1984 in intra day trading.

"Natco Pharma is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India)," the company said in a press release.

Read more about: natco
Story first published: Thursday, March 12, 2015, 12:20 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X